These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20631706)

  • 1. Tiny steps towards an HIV vaccine.
    Willyard C
    Nature; 2010 Jul; 466(7304):S8. PubMed ID: 20631706
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunogenicity of plasmid DNA and adenoviral vectors encoding HIV-1 subtype B env gene].
    Yang HR; Zhang LF; Feng X; Yu SQ; Zhuang ZL; Li HX; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):415-7. PubMed ID: 21604562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in HIV vaccine development.
    Hsu DC; O'Connell RJ
    Hum Vaccin Immunother; 2017 May; 13(5):1018-1030. PubMed ID: 28281871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poxvirus vector-based HIV vaccines.
    Pantaleo G; Esteban M; Jacobs B; Tartaglia J
    Curr Opin HIV AIDS; 2010 Sep; 5(5):391-6. PubMed ID: 20978379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HIV vaccine pipeline, from preclinical to phase III.
    Schultz AM; Bradac JA
    AIDS; 2001; 15 Suppl 5():S147-58. PubMed ID: 11816163
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of HIV-1-specific neutralizing antibodies in mice vaccinated with a recombinant Sendai virus vector.
    Kano M; Matano T; Kato A; Shioda T; Nagai Y
    Jpn J Infect Dis; 2002 Apr; 55(2):59-60. PubMed ID: 12082313
    [No Abstract]   [Full Text] [Related]  

  • 7. HIV vaccine development--improving on natural immunity.
    Johnston MI; Fauci AS
    N Engl J Med; 2011 Sep; 365(10):873-5. PubMed ID: 21899447
    [No Abstract]   [Full Text] [Related]  

  • 8. Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination.
    Martinez DR; Permar SR; Fouda GG
    Clin Vaccine Immunol; 2016 Feb; 23(2):84-94. PubMed ID: 26656117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered Expression of Broadly Neutralizing Antibodies Against Human Immunodeficiency Virus.
    Ahmad M; Ahmed OM; Schnepp B; Johnson PR
    Annu Rev Virol; 2017 Sep; 4(1):491-510. PubMed ID: 28645240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and C.
    Barnett SW; Srivastava IK; Ulmer JB; Donnelly JJ; Rappuoli R
    Microbes Infect; 2005 Nov; 7(14):1386-91. PubMed ID: 16275150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccination of macaques by a full genome HIV-1 plasmid which produces noninfectious virus particles.
    Akahata W; Ido E; Shimada T; Katsuyama K; Yamamoto H; Uesaka H; Ui M; Kuwata T; Takahashi H; Hayami M
    Virology; 2000 Sep; 275(1):116-24. PubMed ID: 11017793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design.
    Zolla-Pazner S; Cardozo T
    Nat Rev Immunol; 2010 Jul; 10(7):527-35. PubMed ID: 20577269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV Vaccines: One Step Closer.
    Low MSY; Tarlinton D
    Trends Mol Med; 2017 Jan; 23(1):1-3. PubMed ID: 27889424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AIDS/HIV. Host controls of HIV neutralizing antibodies.
    Haynes BF; Verkoczy L
    Science; 2014 May; 344(6184):588-9. PubMed ID: 24812389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarification of how HIV-1 DNA and protein immunizations may be better used to obtain HIV-1-specific mucosal and systemic immunity.
    Hinkula J
    Expert Rev Vaccines; 2007 Apr; 6(2):203-12. PubMed ID: 17408370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Requirements for the Induction of Broadly Neutralizing Antibodies against HIV-1 by Vaccination].
    Vzorov AN; Uryvaev LV
    Mol Biol (Mosk); 2017; 51(6):945-957. PubMed ID: 29271959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in synthetic carbohydrate-based human immunodeficiency virus vaccines.
    Wang Z; Qin C; Hu J; Guo X; Yin J
    Virol Sin; 2016 Apr; 31(2):110-7. PubMed ID: 26992403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the irrationality of rational design of an HIV vaccine in light of protein intrinsic disorder.
    Uversky VN
    Arch Virol; 2021 May; 166(5):1283-1296. PubMed ID: 33606110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Vaccine: Recent Advances, Current Roadblocks, and Future Directions.
    Rubens M; Ramamoorthy V; Saxena A; Shehadeh N; Appunni S
    J Immunol Res; 2015; 2015():560347. PubMed ID: 26579546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.
    Stephenson KE; Wagh K; Korber B; Barouch DH
    Annu Rev Immunol; 2020 Apr; 38():673-703. PubMed ID: 32340576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.